triamcinolone has been researched along with Amaurosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Barnes, R; Barry, R; Barthelmes, D; Bhandari, S; Gillies, M; Nguyen, V; Squirrell, D; Tan, T; Wang, N; Wells, JM | 1 |
Fukushima, A; Goto, R; Hikichi, Y; Kitano, S; Sakamoto, T; Vataire, AL | 1 |
Gariano, RF; Paulus, YM | 1 |
POLANO, MK | 1 |
SNEDDON, IB | 1 |
BJOERNBERG, A; BJOERNBERG, K; GISSLEN, H | 1 |
Haritoglou, C; Kampik, A | 1 |
Freilich, DB; Grieco, MH; Louria, DB | 1 |
1 review(s) available for triamcinolone and Amaurosis
Article | Year |
---|---|
Diabetic retinopathy: a growing concern in an aging population.
Topics: Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Blindness; California; Diabetic Retinopathy; Drug Therapy, Combination; Geriatrics; Glucocorticoids; Humans; Incidence; Injections, Intralesional; Laser Coagulation; Mass Screening; Randomized Controlled Trials as Topic; Ranibizumab; Risk Factors; Treatment Outcome; Triamcinolone | 2009 |
7 other study(ies) available for triamcinolone and Amaurosis
Article | Year |
---|---|
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.
Topics: Angiogenesis Inhibitors; Bevacizumab; Blindness; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Registries; Retrospective Studies; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A | 2022 |
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan.
Topics: Aged; Angiogenesis Inhibitors; Blindness; Caregivers; Cost of Illness; Cost-Benefit Analysis; Diabetes Complications; Efficiency; Female; Humans; Intravitreal Injections; Japan; Macular Edema; Male; Markov Chains; Middle Aged; Models, Econometric; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Visual Acuity | 2019 |
Triamcinolone acetonide cream in a double-blind test.
Topics: Blindness; Double-Blind Method; Eczema; Humans; Triamcinolone; Triamcinolone Acetonide | 1961 |
BLIND COMPARATIVE TRIAL OF FLUPEROLONE.
Topics: Administration, Topical; Blindness; Eczema; Hydrocortisone; Methylprednisolone; Prednisolone; Triamcinolone | 1963 |
TOXIC EPIDERMAL NECROLYSIS WITH OPTHALMIC COMPLICATIONS.
Topics: Blindness; Cathartics; Chlordiazepoxide; Corneal Ulcer; Cushing Syndrome; Demeclocycline; Drug Therapy; Eye Manifestations; Glycosuria; Humans; Keratoconjunctivitis; Osteoporosis; Phenacetin; Phenolphthaleins; Pyelonephritis; Stevens-Johnson Syndrome; Toxicology; Triamcinolone | 1964 |
[Surgical therapy of diabetic retinopathy].
Topics: Blindness; Blood Glucose; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Retina; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitreoretinopathy, Proliferative | 2005 |
Diagnosis of cryptococcal uveitis with hypertonic media.
Topics: Agglutination Tests; Amphotericin B; Antigens; Blindness; Cataract; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; Humans; Hypertonic Solutions; Male; Methods; Middle Aged; Retinal Detachment; Rubber; Sucrose; Triamcinolone; Uveitis | 1971 |